Plant-based Vaccines Market, by Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, and Others), by Application (Influenza, Zika Virus, Ebola Virus, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

  • To Be Published : Aug 2018 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Plant-based vaccines are derived from antigens produced in genetically modified plants that can be extracted and purified by conventional methods. These vaccines can either be consumed or applied to mucosal surfaces. Plants that are commonly used in production of vaccines are tobacco, potato, tomato, corn, and rice. Currently, there are several transgenic plants used in development of four different types of vaccines namely: viral vaccines, parasite vaccines, and bacterial vaccines.

Plant-based vaccines can be extensively manufactured at a very cheap cost. Currently, no plant-based vaccine has received approval from the US Food and Drug Administration (FDA), as these vaccines are classified under the genetically modified crop category. However, there are several plant-based vaccines in clinical trials, which are expected to receive approval from FDA during the forecast period.

Plant-Based Vaccines Market Drivers

Increasing number of research and development activities by key players in the market and robust pipeline of plant-based vaccines is expected to be a major factor driving the global plant-based vaccines market growth during the forecast period. For instance, in 2017, Medicago Inc.—a Canada-based biopharmaceutical company that focuses on development of plant-based vaccines—initiated phase 3 clinical trial to evaluate efficacy of its seasonal quadrivalent influenza vaccine (QIV) candidate. The trial comprises around 10,000 subjects in the following countries: the U.S., Canada, Germany, the U.K., the Philippines, Finland, and Thailand. QIV was developed using a new virus-like particle (VLP) technology, which is an alternative to egg-based and cell-based production systems.

Furthermore, in 2017, researchers from the Arizona State University (ASU), in the U.S., developed the first plant-based Zika vaccine. According to the university, the newly developed plant-based Zika vaccine is safer, potent, and its production cost is much cheaper. Such robust pipeline of plant-based vaccines is expected to be a major factor in growth of the global plant-based vaccines market during the forecast period.

Moreover, various government initiatives for development of plant-based vaccines are also expected to fuel the plant-based vaccines market growth during the forecast period. For instance, in 2015, Public Health Agency of Canada (PHAC) granted a contract to Medicago Inc. for development of two plant-based vaccines for Sudan strain of Ebola virus.

High prevalence of viruses such as Influenza, Zika virus, and Ebola is expected to increase demand for plant-based vaccines, which in turn is expected to propel growth of the plant-based vaccines market. For instance, according to a report published by Centers for Disease Control and Prevention (CDC), in October 2016, around 140,000 to 710,000 influenza related patients were hospitalized and around 12,000 to 56,000 influenza related deaths were registered, since 2010.

According to a report by the International Journal of Topical Disease & Health, in 2016, between1976-2015, there were around 24 outbreaks of Ebola virus disease in several regions of West-African countries. The most recent outbreak in 2015, reported around 24,350 cases and around 10,004 deaths.

Plant-Based Vaccines Market Regional Analysis

North America is expected to be dominant in the global plant vaccines market over the forecast period. This is owing to high prevalence of infectious disease such as Ebola and Influenza in the region. For instance, according to a study by Influenza Research Center, 2014, influenza is responsible for substantial morbidity and mortality, with an average of over 100,000 hospitalizations and around 20,000 deaths, annually in the U.S.

Asia Pacific plant-based vaccines market is expected to show significant growth during the forecast period, owing to increasing number of collaborations and acquisitions between key players in the region. For instance, in 2013, Japan-based pharmaceutical company—Mitsubishi Tanabe Pharma Corporation—acquired Medicago Inc., a Canada-based biopharmaceutical company, focused on development of new plant-based vaccines. Furthermore, Mitsubishi Tanabe Pharma Corporation acquired 60% share of Medicago Inc. at total amount of US$ 357 million. The other 40% share is owned by an investment group, Philip Morris Investments B.V.

Plant-Based Vaccines Market Key Players

Key players operating in the global plant-based vaccines market include Medicago Inc., Mitsubishi Tanabe Pharma Corporation, iBio, Inc., Fraunhofer Center for Molecular Biotechnology (CMB), Protalix BioTherapeutics, and others.

Plant-Based Vaccines Market Taxonomy:

The global plant based vaccines market is segmented on the basis of vaccine type, application, and region

By Vaccine Type-

  • Bacterial Vaccines
  • Viral Vaccines
  • Parasite Vaccines
  • Others

By Application-

  • Influenza
  • Zika Virus
  • Ebola Virus
  • Others

By Geography-

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.